Immune cells from your own tumor: a new hope for advanced cancers?
NCT ID NCT07255664
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 26 times
Summary
This early-stage trial tests a new treatment for people with metastatic colorectal or prostate cancer. The treatment uses immune cells (TILs) taken from the patient's own tumor, grown in a lab, and then given back to the patient multiple times. The main goals are to see if it is safe and feasible, and to check for any signs of tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Krankenhaus Nordwest
RECRUITINGFrankfurt, 60488, Germany
Contact
Conditions
Explore the condition pages connected to this study.